Editor's Note
This study by researchers at Rutgers New Jersey Medical School finds that treatment for COVID-19 should be based on clinical judgment and not just testing.
Between April and October 2020, the researchers looked at four groups:
The researchers found that Probables had a similar antibody profile as those who were RT-PCR confirmed COVID-19 patients, and Suspects had a similar antibody profile as Nonsuspects.
They also found that only 43% of the severely-ill Probables received COVID-19 treatment compared to 79% of severely-ill RT-PCR confirmed positive patients.
These findings emphasize the critical role that clinical diagnosis has in determining whether to treat a COVID-19 patient and that clinicians should not rely solely on RT-PCR tests, the researchers say.
Read More >>